US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Chorus Ltd (PK) (CHRUF) 銘柄情報

Chorus Ltd (PK) (CHRUF)

5.66

0.00

(0.00%)

終了 7月4日 5:00AM

Chorus Ltd (PK) (CHRUF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

5.66

( - )

買値

5.08

売値

6.09

出来高

600

0.00 日の範囲 0.00

5.15 52 週間の範囲 5.66

時価総額

前日終値

5.66

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 266,921

発行済株式数

433,887,294

配当利回り

0.59 (6.19%)

PER

259.48

1 株当たり利益 (EPS)

0.04

歳入

1.02B

純利益

24M

Chorus Limited, together with its subsidiaries, engages in the provision of fixed line communications infrastructure services in New Zealand. It offers wholesale broadband, data, and voice services. The company also builds and maintains a network of fiber and copper cables, ducts, poles, network ele... Chorus Limited, together with its subsidiaries, engages in the provision of fixed line communications infrastructure services in New Zealand. It offers wholesale broadband, data, and voice services. The company also builds and maintains a network of fiber and copper cables, ducts, poles, network electronics, and cabinets. In addition, it provides value-added network services; physical storage and site-sharing rental services for co-location of third party or shared asset; and installation, wiring, and consultation services. Chorus Limited was incorporated in 2011 and is based in Wellington, New Zealand. 詳細を表示

セクター

Media

業界

Telecommunications

ウェブサイト

www.chorus.co.nz

本社

Wellington, New Zealand

設立

2026

Chorus Ltd (PK) is listed in the Media sector of the その他OTC with ticker CHRUF. The last closing price for Chorus (PK) was US$5.66. Over the last year, Chorus (PK) shares have traded in a share price range of US$ 5.15 to US$ 5.66.

Chorus (PK) currently has 433,887,294 shares in issue. The market capitalisation of Chorus (PK) is US$2.46 billion. Chorus (PK) has a price to earnings ratio (PE ratio) of 259.48.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0.0856	1.5355912744	5.5744	5.66	5.5744	650	5.63634303	CS
12	0.51	9.90291262136	5.15	5.66	5.15	27098	5.15466278	CS
26	0.13	2.35081374322	5.53	5.66	5.15	15067	5.15465899	CS
52	0.31	5.79439252336	5.35	5.66	5.15	6425	5.16990972	CS
156	0.98	20.9401709402	4.68	5.66	3.93	3396	5.07814817	CS
260	1.03	22.2462203024	4.63	5.66	3.78	2831	5.07372504	CS

CHRUF - Frequently Asked Questions (FAQ)

What is the current Chorus Ltd (PK) share price?

The current share price of Chorus Ltd (PK) is US$ 5.66

How many Chorus Ltd (PK) shares are in issue?

Chorus Ltd (PK) has 433,887,294 shares in issue

What is the market cap of Chorus Ltd (PK)?

The market capitalisation of Chorus Ltd (PK) is USD 2.46B

What is the 1 year trading range for Chorus Ltd (PK) share price?

Chorus Ltd (PK) has traded in the range of US$ 5.15 to US$ 5.66 during the past year

What is the PE ratio of Chorus Ltd (PK)?

The price to earnings ratio of Chorus Ltd (PK) is 259.48

What is the cash to sales ratio of Chorus Ltd (PK)?

The cash to sales ratio of Chorus Ltd (PK) is 4.21

What is the registered address of Chorus Ltd (PK)?

The registered address for Chorus Ltd (PK) is 1 Willis Street, Wellington, 6011

What is the Chorus Ltd (PK) website address?

The website address for Chorus Ltd (PK) is www.chorus.co.nz

Which industry sector does Chorus Ltd (PK) operate in?

Chorus Ltd (PK) operates in the Telecommunications sector

Whalatane

Whalatane 3分前

Are U up about 10X on this ??

Kiwi

Whalatane

Whalatane 4分前

Karen Firestone from CNBC ..ex Fidelity biotech fund manager I think
Karen Firestone (Amylyx Board Member): She is the co-founder, CEO, and Chairman of Aureus Asset Management.
She sits on the Amylyx Board as a member of both the Audit and the Nominating and Corporate Governance comm

sentiment_stocks

sentiment_stocks 4分前

Interesting, too, that using the MAIC actually underestimated the results, erring on the side of extreme caution in presenting the results.

I'm guessing no one, including the company, the regulators, and even (especially?) the shorts thought that applying Individual Patient Data (IPD)

ErnieBilco

ErnieBilco 4分前

Sounds like a winner to me.

DayofReckoning

DayofReckoning 6分前

$TWOH Just like OTC message boards are notorious for mentioning RS just for the heck of it

Johnnycombat10

Johnnycombat10 6分前

New Substack article today! Gearing up for something me thinks.

fredscott36

fredscott36 6分前

the ZRI-X's are super cool, BAD SUNNY........twice the price and for some reason............hated by vette people.......??.......and the sales and depreciation are wicked........????..........no worries, BAD SUNNY...................

produce on those UWBI cusips and I will be dropping

Hotel Delta

Hotel Delta 6分前

I think this company is dead. Very little hope left after owning it for 19 years

HappyLibrarian

HappyLibrarian 7分前

I will be buying more at this cheap price starting Monday morning.Our time for cheap shares is running out.

Don’t jinx it.

Every time someone says that, you turn around a year later and it’s still cheap.

That said, LC might be just have to be disappoint

doccjc

doccjc 10分前

Anyone else notice the bashers are promoting the glue company?
Should explain why they are here.
They'll deny it, but it's pretty obvious.
Ignore them.
Don't give them a platform.
IDE decision Monday?

HappyLibrarian

HappyLibrarian 10分前

Simply put, this data not only puts to rest but absolutely crushes every single bear criticism of the original trial result readout and analysis.

Even Nemisis has immediately changed his tune from “DCVax was DOA as soon as the application was submitted” to “well we still have to wait

TradingCharts

TradingCharts 12分前

https://www.alexandertechnologies.com/our-manufacturing-capabilities/

HappyLibrarian

HappyLibrarian 13分前

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model. Please notice that EXPANSION of

GoodGuyBill

GoodGuyBill 13分前

UK BNOS 2026 slides are available https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf here !!!

Slides below:

https://investorshub.advfn.com/uimage/uploads/2026/7/3/k[ferSlide1.jpg

https://investorshub.advfn.com/uimage/uploads/20

Whalatane

Whalatane 14分前

To correct myself ....:---)
What Actually Drove Guggenheim's Model Increase?
Guggenheim raised its price target on Amylyx to $40 due to structural dynamics specific to the Post-Bariatric Hypoglycemia (PBH) market rather than public diabetic trends

:Solving a Critical Co

goldfinger

goldfinger 14分前

I will be buying more at this cheap price starting Monday morning.Our time for cheap shares is running out.

SSKILLZ1

SSKILLZ1 14分前

Well the selling spree yesterday has made me jump to 72% cash (Highest since like late September of last year), I don't expect to be here long as I think a lot of stocks are going to sell off over the next week or two, I think in general stocks will be found 5-15% cheaper because of what I feel is a

beartrap12

beartrap12 15分前

Dr. Bosch's presentation: Very Positive!!
I attempted to recreate the chart on pg. 6 into sentences, just including the 5 yr (60 mo.) data. Go to the chart for lots more info.

Newly diagnosed GBM (survival rate):
More than doubled 5-year survival
‘Long Ta

Sunnybank

Sunnybank 15分前

Splurge, Go Green ZR1X Electric motor up front, AWD, 1000+ horsepower; check it out on YouTube. Will dust anything on the road, even the Bugatti Veyron. Hell buy 2or 3 great investment IMO.

FeMike

FeMike 17分前

Simply put, this data not only puts to rest but absolutely crushes every single bear criticism of the original trial result readout and analysis.

Even Nemisis has immediately changed his tune from “DCVax was DOA as soon as the application was submitted” to “well we still have to wait

Doc logic

Doc logic 18分前

barnstormer,

Evidently the wiring/electrical had to be reconfigured in the modified clean room space being fitted out for Class C clean room space. Best wishes.

HappyLibrarian

HappyLibrarian 19分前

However... Due to their steadfastness... You may yet get to enjoy ordering some gourmet crow online and eat it.

My remark about eating crow is specific to Dr. Bosch’s presentation of which much has been made by some (though fewer than you’d expect as shareholders tacitly wise

jay_tee

jay_tee 20分前

Dealing with FOXO was a pointless venture. Seamus does absolutely no due diligence when making business decisions. The board members are buffoons also… how can everyone in that room be so damn incompetent??? Like I said Seamus must have some serious dirt on everyone involved to be able to continue h

boston745

boston745 20分前

That is not my problem. People get lumped together when their actions align with each other and their actions align with mgmt true intentions.
As far as finding you saying that specific quote, I will not find it. Thats something mainly found with Atlanta and I believe Madg. The part that say

AngeloFoca

AngeloFoca 20分前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/bzusrnwbo_11.jpg

1.1250% until 7/24/2028 ...

Gascoyne Resources

PreveCeutical Medical (QB)

Belgium Utilities

Abacus Property

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。